Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,030 public trials 1,171 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

NCT04105270

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations
  • Dr. Amit Kulkarni Phoenix, Arizona, United States
  • MNCCTN Essentia Health St. Joseph's Brainerd Medical Center Brainerd, Minnesota, United States
  • MNCCTN Essentia Health Deer River Deer River, Minnesota, United States
  • MNCCTN Essentia Health St. Mary's Detroit Lakes Clinic Detroit Lakes, Minnesota, United States
View Trial Details
Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

NCT04510597

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 387 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NCT06682793

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Recruiting

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

NCT05919108

Conditions
Adenocarcinoma, Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, +13 more
Locations
  • Emory University/ Winship Cancer Institute Atlanta, Georgia, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
  • University of Texas, Southwestern Dallas, Texas, United States
View Trial Details

Related conditions